HST Global Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
0.20
0.20
0.20
0.50
0.30
122,567.01
Total Current Assets
0.20
0.20
0.20
0.50
0.30
-
Total Assets
0.20
0.20
0.20
0.50
0.30
-
ST Debt & Current Portion LT Debt
798.20
1,231.10
1,299.50
1,321.70
1,351.40
Accounts Payable
918.20
-
-
-
-
Other Current Liabilities
757.90
1,427.80
1,555.20
1,706.30
1,841.50
Total Current Liabilities
2,474.20
2,658.90
2,854.70
3,028.00
3,192.90
Total Liabilities
2,474.20
2,658.90
2,854.70
3,028.00
3,192.90
Common Equity (Total)
2,474.00
2,658.70
2,854.50
3,027.50
3,192.60
Total Shareholders' Equity
2,474.00
2,658.70
2,854.50
3,027.50
3,192.60
Total Equity
2,474.00
2,658.70
2,854.50
3,027.50
3,192.60
Liabilities & Shareholders' Equity
0.20
0.20
0.20
0.50
0.30

About HST Global

View Profile
Address
150 Research Drive
Hampton Virginia 23666
United States
Employees -
Website http://www.hstglobal.com
Updated 07/08/2019
HST Global, Inc. is a biotechnology and wellness company. The company discovers and develops breakthroughs in supporting and treating metabolic disorders associated with cancer and other life threatening illnesses. It develops and acquires a network of wellness centers, that are focused on the homeopathic and alternative treatment of stage cancer.